SNP23_HUMAN - dbPTM
SNP23_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID SNP23_HUMAN
UniProt AC O00161
Protein Name Synaptosomal-associated protein 23
Gene Name SNAP23
Organism Homo sapiens (Human).
Sequence Length 211
Subcellular Localization Cell membrane
Peripheral membrane protein. Cell membrane
Lipid-anchor. Cell junction, synapse, synaptosome. Mainly localized to the plasma membrane.
Protein Description Essential component of the high affinity receptor for the general membrane fusion machinery and an important regulator of transport vesicle docking and fusion..
Protein Sequence MDNLSSEEIQQRAHQITDESLESTRRILGLAIESQDAGIKTITMLDEQKEQLNRIEEGLDQINKDMRETEKTLTELNKCCGLCVCPCNRTKNFESGKAYKTTWGDGGENSPCNVVSKQPGPVTNGQLQQPTTGAASGGYIKRITNDAREDEMEENLTQVGSILGNLKDMALNIGNEIDAQNPQIKRITDKADTNRDRIDIANARAKKLIDS
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MDNLSSEE
-------CCCCCHHH
7.5120068231
5Phosphorylation---MDNLSSEEIQQR
---CCCCCHHHHHHH
41.7923401153
5 (in isoform 1)Phosphorylation-41.79-
6Phosphorylation--MDNLSSEEIQQRA
--CCCCCHHHHHHHH
42.2729255136
6 (in isoform 1)Phosphorylation-42.27-
17PhosphorylationQQRAHQITDESLEST
HHHHHHCCHHHHHHH
27.4323898821
20PhosphorylationAHQITDESLESTRRI
HHHCCHHHHHHHHHH
40.0023401153
20 (in isoform 1)Phosphorylation-40.00-
23PhosphorylationITDESLESTRRILGL
CCHHHHHHHHHHHHH
32.2923401153
23 (in isoform 1)Phosphorylation-32.29-
24PhosphorylationTDESLESTRRILGLA
CHHHHHHHHHHHHHH
18.0029255136
24 (in isoform 1)Phosphorylation-18.00-
34PhosphorylationILGLAIESQDAGIKT
HHHHHHHCCCCCCEE
27.5230266825
34 (in isoform 1)Phosphorylation-27.52-
40 (in isoform 1)Ubiquitination-32.7221906983
40 (in isoform 2)Ubiquitination-32.7221906983
40UbiquitinationESQDAGIKTITMLDE
HCCCCCCEEEEEHHH
32.7221906983
44SulfoxidationAGIKTITMLDEQKEQ
CCCEEEEEHHHHHHH
3.8221406390
49 (in isoform 1)Ubiquitination-45.4321906983
49UbiquitinationITMLDEQKEQLNRIE
EEEHHHHHHHHHHHH
45.4321906983
49 (in isoform 2)Ubiquitination-45.4321906983
64 (in isoform 1)Ubiquitination-55.3121906983
64UbiquitinationEGLDQINKDMRETEK
HHHHHHHHHHHHHHH
55.3121906983
64 (in isoform 2)Ubiquitination-55.3121906983
69PhosphorylationINKDMRETEKTLTEL
HHHHHHHHHHHHHHH
32.2023312004
71UbiquitinationKDMRETEKTLTELNK
HHHHHHHHHHHHHHH
57.14-
72PhosphorylationDMRETEKTLTELNKC
HHHHHHHHHHHHHHH
32.4523312004
74PhosphorylationRETEKTLTELNKCCG
HHHHHHHHHHHHHCC
43.5923312004
79S-palmitoylationTLTELNKCCGLCVCP
HHHHHHHHCCEEEEC
1.8531142470
80S-palmitoylationLTELNKCCGLCVCPC
HHHHHHHCCEEEECC
5.0731142470
83S-palmitoylationLNKCCGLCVCPCNRT
HHHHCCEEEECCCCC
1.4731142470
85S-palmitoylationKCCGLCVCPCNRTKN
HHCCEEEECCCCCCC
2.8731142470
87S-palmitoylationCGLCVCPCNRTKNFE
CCEEEECCCCCCCCC
4.5631142470
91UbiquitinationVCPCNRTKNFESGKA
EECCCCCCCCCCCCE
57.30-
95PhosphorylationNRTKNFESGKAYKTT
CCCCCCCCCCEEECC
41.2622817900
97AcetylationTKNFESGKAYKTTWG
CCCCCCCCEEECCCC
58.8025953088
97UbiquitinationTKNFESGKAYKTTWG
CCCCCCCCEEECCCC
58.80-
99PhosphorylationNFESGKAYKTTWGDG
CCCCCCEEECCCCCC
16.6228450419
100UbiquitinationFESGKAYKTTWGDGG
CCCCCEEECCCCCCC
44.32-
101PhosphorylationESGKAYKTTWGDGGE
CCCCEEECCCCCCCC
18.3322167270
102PhosphorylationSGKAYKTTWGDGGEN
CCCEEECCCCCCCCC
24.2522167270
108 (in isoform 1)Phosphorylation-61.13-
110PhosphorylationWGDGGENSPCNVVSK
CCCCCCCCCCCEEEC
26.9119664994
112S-palmitoylationDGGENSPCNVVSKQP
CCCCCCCCCEEECCC
6.4021044946
112S-nitrosylationDGGENSPCNVVSKQP
CCCCCCCCCEEECCC
6.402212679
116PhosphorylationNSPCNVVSKQPGPVT
CCCCCEEECCCCCCC
22.6923927012
117UbiquitinationSPCNVVSKQPGPVTN
CCCCEEECCCCCCCC
49.23-
123PhosphorylationSKQPGPVTNGQLQQP
ECCCCCCCCCCCCCC
36.4426074081
131PhosphorylationNGQLQQPTTGAASGG
CCCCCCCCCCCCCCC
33.2621945579
132PhosphorylationGQLQQPTTGAASGGY
CCCCCCCCCCCCCCC
31.3521945579
132 (in isoform 2)Ubiquitination-31.3521906983
136PhosphorylationQPTTGAASGGYIKRI
CCCCCCCCCCCEEEC
32.0121945579
139PhosphorylationTGAASGGYIKRITND
CCCCCCCCEEECCCC
13.5421945579
141 (in isoform 1)Ubiquitination-29.3021906983
141UbiquitinationAASGGYIKRITNDAR
CCCCCCEEECCCCCC
29.3021906983
144PhosphorylationGGYIKRITNDAREDE
CCCEEECCCCCCHHH
30.9528270605
157PhosphorylationDEMEENLTQVGSILG
HHHHHHHHHHHHHHH
32.5626657352
161PhosphorylationENLTQVGSILGNLKD
HHHHHHHHHHHHHHH
18.7825159151
169SulfoxidationILGNLKDMALNIGNE
HHHHHHHHHHHCCCC
4.3421406390
185 (in isoform 1)Ubiquitination-32.2821906983
185UbiquitinationDAQNPQIKRITDKAD
CCCCCCHHHHCCCCC
32.282190698
190UbiquitinationQIKRITDKADTNRDR
CHHHHCCCCCCCHHH
39.24-
193PhosphorylationRITDKADTNRDRIDI
HHCCCCCCCHHHHHH
36.6927470641
211PhosphorylationRAKKLIDS-------
HHHHHHCC-------
34.8226074081

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
23SPhosphorylationKinaseKPCAP17252
PhosphoELM
23SPhosphorylationKinasePRKCAP05696
GPS
24TPhosphorylationKinaseKPCAP17252
PhosphoELM
24TPhosphorylationKinasePRKCAP05696
GPS
95SPhosphorylationKinaseIKBKBO14920
GPS
95SPhosphorylationKinasePRKCAP05696
GPS
95SPhosphorylationKinasePKMP14618
PSP
161SPhosphorylationKinaseKPCAP17252
PhosphoELM
161SPhosphorylationKinasePRKCAP05696
GPS

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of SNP23_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of SNP23_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
SNAPN_HUMANSNAPINphysical
12877659
ABI2_HUMANABI2physical
16189514
ABI3_HUMANABI3physical
16189514
SEGN_HUMANSCGNphysical
16189514
FXR2_HUMANFXR2physical
16189514
SNAA_HUMANNAPAphysical
16189514
SNTG1_HUMANSNTG1physical
12877659
STXB5_HUMANSTXBP5physical
12832401
STX2_HUMANSTX2physical
12828989
STX3_HUMANSTX3physical
12828989
STX4_HUMANSTX4physical
12828989
VAMP2_HUMANVAMP2physical
12828989
VAMP3_HUMANVAMP3physical
12828989
VAMP8_HUMANVAMP8physical
12828989
STX1A_HUMANSTX1Aphysical
9168999
STX2_HUMANSTX2physical
9168999
STX3_HUMANSTX3physical
9168999
STX4_HUMANSTX4physical
9168999
KINH_HUMANKIF5Bphysical
12475239
STX12_HUMANSTX12physical
9507000
VAMP2_HUMANVAMP2physical
10820264
VAMP8_HUMANVAMP8physical
10820264
VAMP3_HUMANVAMP3physical
10820264
STX4_HUMANSTX4physical
10820264
STX11_HUMANSTX11physical
10036234
SCAM1_HUMANSCAMP1physical
12124380
SCAM2_HUMANSCAMP2physical
12124380
STX4_HUMANSTX4physical
10713150
STX6_HUMANSTX6physical
11001914
STX4_HUMANSTX4physical
12556468
VAMP3_HUMANVAMP3physical
12556468
MATR3_HUMANMATR3physical
21900206
STX11_HUMANSTX11physical
21900206
STX4_HUMANSTX4physical
22939629
UBQL2_HUMANUBQLN2physical
22939629
YES_HUMANYES1physical
22939629
SNP23_HUMANSNAP23physical
25416956
VAMP5_HUMANVAMP5physical
25416956
SNAB_HUMANNAPBphysical
25416956
STX2_HUMANSTX2physical
10820264
CHM2A_HUMANCHMP2Aphysical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of SNP23_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT THR-102 AND SER-110, AND MASS SPECTROMETRY.
"Exploring proteomes and analyzing protein processing by massspectrometric identification of sorted N-terminal peptides.";
Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,Thomas G.R., Vandekerckhove J.;
Nat. Biotechnol. 21:566-569(2003).
Cited for: PROTEIN SEQUENCE OF 1-12, AND ACETYLATION AT MET-1.
Palmitoylation
ReferencePubMed
"Site-specific analysis of protein S-acylation by resin-assistedcapture.";
Forrester M.T., Hess D.T., Thompson J.W., Hultman R., Moseley M.A.,Stamler J.S., Casey P.J.;
J. Lipid Res. 52:393-398(2011).
Cited for: PALMITOYLATION AT CYS-79; CYS-80; CYS-83; CYS-85; CYS-87 AND CYS-112.
Phosphorylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT THR-102 AND SER-110, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-110, AND MASSSPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6, AND MASSSPECTROMETRY.
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.;
Anal. Sci. 24:161-166(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-110, AND MASSSPECTROMETRY.

TOP